Literature DB >> 16733790

Subcellular localisation of VEGF in different pituitary cells. Changes of its expression in oestrogen induced prolactinomas.

Jorge Humberto Mukdsi1, Ana Lucía De Paul, Silvina Gutiérrez, Félix Daniel Roth, Agustín Aoki, Alicia Inés Torres.   

Abstract

Vascular endothelial growth factor (VEGF) is an important angiogenic factor in the pituitary gland. The objective of this study was to unveil the VEGF subcellular localisation in different pituitary cell types and to evaluate changes in its expression at different time intervals after oestrogen stimulation. A relevant feature demonstrated was the identification of this cytokine in the nucleus and cytoplasm of lactotrophs, somatotrophs and gonadotrophs, as well as in follicle-stellate cells of male rats. Oestrogen treatment increased the number of VEGF immunopositive cells and its expression detected differentially by western blot in both nucleus and cytoplasm of pituitary cells when compared to the control. At ultrastructural level VEGF appeared associated with nucleolus and euchromatin involving a possible internal autocrine loop. In lactotrophs, the predominant cell of the tumour, VEGF was immunodetected in RER, Golgi complex, and vesicular organelles, supporting further the association with an auto-paracrine effect exerted by VEGF. The nucleus/cytoplasm ratio of VEGF revealed a prevalent accumulation of VEGF in the cytoplasm. The presence of VEGF in the nucleus may probably be associated with a translocation to this cell compartment. This study demonstrated a cytoplasmic and nuclear immunolocalisation of VEGF in normal and tumoural adenohypophyseal cells. In the course of prolactinoma development, the oestrogen stimulated VEGF expression in tumoural cells, promoting a vascular adaptation which contributes to growth and progression of the tumour.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16733790     DOI: 10.1007/s10735-005-9012-7

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  42 in total

Review 1.  Toward a theory of intracrine hormone action.

Authors:  Richard N Re
Journal:  Regul Pept       Date:  2002-06-15

2.  Increased pituitary vascular endothelial growth factor-a in dopaminergic D2 receptor knockout female mice.

Authors:  C Cristina; G Díaz-Torga; A Baldi; A Góngora; M Rubinstein; M J Low; D Becú-Villalobos
Journal:  Endocrinology       Date:  2005-04-07       Impact factor: 4.736

3.  Immunolocalization of vascular endothelial growth factor in the GH3 cell line.

Authors:  S Vidal; M C Oliveira; K Kovacs; B W Scheithauer; R Lloyd
Journal:  Cell Tissue Res       Date:  2000-04       Impact factor: 5.249

Review 4.  The role of hormones, growth factors and their receptors in pituitary tumorigenesis.

Authors:  S Ezzat
Journal:  Brain Pathol       Date:  2001-07       Impact factor: 6.508

5.  Improvement of prolactin immunolabelling in osmium-fixed acrylic-embedded pituitary gland.

Authors:  C A Maldonado; A Aoki
Journal:  Basic Appl Histochem       Date:  1986

6.  Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells.

Authors:  N Ferrara; W J Henzel
Journal:  Biochem Biophys Res Commun       Date:  1989-06-15       Impact factor: 3.575

7.  Nuclear localization of long-VEGF is associated with hypoxia and tumor angiogenesis.

Authors:  Yifat Rosenbaum-Dekel; Alisa Fuchs; Evgeny Yakirevich; Aviva Azriel; Salam Mazareb; Murray B Resnick; Ben-Zion Levi
Journal:  Biochem Biophys Res Commun       Date:  2005-06-24       Impact factor: 3.575

8.  VEGF-induced mobilization of caveolae and increase in permeability of endothelial cells.

Authors:  Jun Chen; Filip Braet; Sergey Brodsky; Talia Weinstein; Victor Romanov; Eisei Noiri; Michael S Goligorsky
Journal:  Am J Physiol Cell Physiol       Date:  2002-05       Impact factor: 4.249

9.  VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism.

Authors:  Hans-Peter Gerber; Ajay K Malik; Gregg P Solar; Daniel Sherman; Xiao Huan Liang; Gloria Meng; Kyu Hong; James C Marsters; Napoleone Ferrara
Journal:  Nature       Date:  2002-06-27       Impact factor: 49.962

10.  Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells.

Authors:  L J Schedlich; T F Young; S M Firth; R C Baxter
Journal:  J Biol Chem       Date:  1998-07-17       Impact factor: 5.157

View more
  4 in total

1.  VEGF and CD31 association in pituitary adenomas.

Authors:  Carolina Cristina; María Inés Perez-Millan; Guillermina Luque; Raúl Ariel Dulce; Gustavo Sevlever; Silvia Inés Berner; Damasia Becu-Villalobos
Journal:  Endocr Pathol       Date:  2010-09       Impact factor: 3.943

2.  Influence of growth and transcriptional factors, and signaling molecules on early human pituitary development.

Authors:  Mirna Bazina; Katarina Vukojevic; Damir Roje; Mirna Saraga-Babic
Journal:  J Mol Histol       Date:  2009-11-17       Impact factor: 2.611

3.  Secretion of VEGF-165 has unique characteristics, including shedding from the plasma membrane.

Authors:  Maria Luisa Guzmán-Hernández; Gael Potter; Kristóf Egervári; Jozsef Z Kiss; Tamas Balla
Journal:  Mol Biol Cell       Date:  2014-02-05       Impact factor: 4.138

Review 4.  Induction stage-dependent expression of vascular endothelial growth factor and aquaporin-1 in diethylstilbestrol-treated rat pituitary.

Authors:  W Zhao; H Shen; F Yuan; G Li; Y Sun; Z Shi; Y Zhang; Z Wang
Journal:  Eur J Histochem       Date:  2009-03-31       Impact factor: 3.188

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.